AUM Pharmaceuticals recalled 50,000 cartons of Quick Touch Alcohol Prep Pads on July 21, 2025, due to cGMP deviations. The recall affects sterile pads containing 70% isopropyl alcohol. Consumers should stop using the product immediately and contact the manufacturer.
cGMP Deviations
Consumers and healthcare providers should stop using this product immediately. Contact YANGZHOU YULOU PAPER PRODUCTS CO., LTD or your healthcare provider for guidance. Notification method: Letter
The recall involves Quick Touch Alcohol Prep Pads, Lot #: 20240610, and an expiration date of June 2029. The product comes in cartons containing 100 sterile pads each. A total of 500 cases were distributed.
The recall stems from deviations in current Good Manufacturing Practices (cGMP), which could compromise product safety and efficacy. Such deviations can lead to contamination or reduced potency of the alcohol prep pads.
No specific incidents or injuries have been reported related to this recall. However, the potential risks associated with cGMP deviations warrant immediate action.
Consumers should stop using the Quick Touch Alcohol Prep Pads immediately. For further guidance, contact YANGZHOU YULOU PAPER PRODUCTS CO., LTD or consult a healthcare provider.
For assistance, reach out to YANGZHOU YULOU PAPER PRODUCTS CO., LTD. More information is available at the FDA's official recall notice.
Glenmark Pharmaceuticals Inc. recalled 13,824 tubes of Azelaic Acid Gel on September 17, 2025. The recall stems from market complaints regarding a gritty texture. Consumers should stop using the product immediately and contact their healthcare provider.
Skin MD by Dr Monika Kiripolsky recalled its Body Acne Cleanser on September 12, 2025. The recall follows the discovery of elevated benzene levels in the product. This contamination poses a high health risk to consumers in California and Georgia.
Private Label Skin Care recalled its Micronized BPO Gel Cleanser 10% on September 12, 2025. Elevated benzene levels prompted the recall in California and Georgia. Consumers must stop using the product immediately and seek guidance from healthcare providers.